| Serial Number | 98667074 |
| Word Mark | IDEA TO CLINIC |
| Filing Date | Thursday, July 25, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 26, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 1, 2025 |
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platform for others in the nature of custom manufacturing, custom biomanufacturing manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology |
| Goods and Services | Scientific research, development, and consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; Scientific research in the field of genetic engineering; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; provision of information in the field of scientific research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services in the field of the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; preparation of reports in the nature of providing information about scientific research in the field of biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and protein |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 25, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NATIONAL RESILIENCE, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | BLUE ASH, OH 45242 |
| Party Name | National Resilience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | National Resilience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Thursday, July 25, 2024 | NEW APPLICATION ENTERED |
| Thursday, July 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 3, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, February 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 11, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 4, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, March 4, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, March 4, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, May 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 29, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 29, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 29, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 29, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 29, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 25, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 1, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 1, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 26, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, February 11, 2026 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, February 11, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 11, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 11, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 11, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |